La Roche-Posay Toleriane Dermallergo Soothing Eye Cream For Sensitive Skin 20Ml

Sephora £21.00 Go to Sephora First seen in Oct 2022
Description
A lightweight soothing fluid formula that is clinically proven to hydrate skin and alleviate signs of skin discomfort and sensitivity around the eyes. Toleriane Dermallergo Eyes reinforces the skin barrier function and provides up to 48h hydration for immediate relief. Approved by Allergy UK, the gentle formula helps reduce redness and itchiness associated with dry skin. Its fresh fluid texture leaves the eye contour feeling comfortable. Specifically formulated for sensitive to ultra-sensitive eye contour area prone to dryness, tightness, redness, and itchiness. Suitable for use with contact lenses. Also suitable for use on allergy-prone skin and eczema-prone skin. Key Benefits: - Up to 48h hydration for immediate relief - Reinforces & protects the skin barrier in 1 hour - Minimalist, hypoallergenic formula approved by Allergy UK - Clinically proven to hydrate skin and reduce signs of sensitivity such as dryness, tightness, and itchiness. Active Ingredients: Toleriane Dermallergo Eyes is enriched with probiotic derived fractions and neurosensine. Combined with Thermal Spring Water from La Roche-Posay, this formula immediately hydrates and relieves the eye contour area. Dermatologically Tested: This gentle comforting fluid has been through rigorous testing under dermatological control to ensure it is suitable for use on sensitive skin and allergy-prone skin. Minimalist Hypoallergenic Formula: The minimalist formula is designed for sensitive skin and its needs. Tested and re-tested for its efficacy and mildness on sensitive skin. The formula is also hypoallergenic. 9/10 UK Dermatologists Recommend La Roche-posay For Sensitive Skin*. *Survey conducted on 267 dermatologists by La Roche-Posay in the UK, July 2019.
You may also like
Discover more
We may earn a commission when you use our links to visit a store and make a purchase. We use cookies to enhance your experience with us. Read more. OK